Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCELLULAR AND MOLECULAR

Effects of Dinucleoside Polyphosphates on Trabecular Meshwork Cells and Aqueous Humor Outflow Facility

David Soto, Jesús Pintor, Assumpta Peral, Arcadi Gual and Xavier Gasull
Journal of Pharmacology and Experimental Therapeutics September 2005, 314 (3) 1042-1051; DOI: https://doi.org/10.1124/jpet.105.085274
David Soto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jesús Pintor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Assumpta Peral
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arcadi Gual
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xavier Gasull
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The most important risk factor for the development of glaucoma is elevated intraocular pressure (IOP). Hypotensive drugs decrease IOP, preventing optic nerve damage and further vision loss. The balance between aqueous humor (AH) production and drainage determines IOP, and problems in AH outflow pathways are associated with open-angle glaucoma development. Previous studies have shown the presence of diadenosine tetraphosphate (Ap4A) and pentaphosphate (Ap5A) in the AH. Topic application of Ap4A to the cornea decreased IOP, whereas Ap5A increased it. Because dinucleoside polyphosphates stimulate P2Y purinergic receptors, we studied their presence in trabecular meshwork (TM) cells. Additionally, the effects of diadenosine polyphosphates (ApnAs; n = 3–5) and Up4U (P1,P4-(diuridine 5′)-tetraphosphate; INS365) in outflow facility were tested. P2Y1, P2Y2, and P2Y4 receptors were detected in TM cells by Western blot and immunocytochemistry. In TM cells, Ap3A, Ap4A, and Ap5A induced discrete intracellular calcium concentration ([Ca2+]i) mobilizations compared with higher and more sustained [Ca2+]i mobilizations after Up4U application. In bovine ocular anterior segments perfused at constant pressure, 1 μM Ap3A or Ap4A increased outflow facility, whereas Up4U or Ap5A did not modify it. 2-MeSADP, a selective P2Y1 agonist, induced outflow facility increases similar to those obtained after Ap3A and Ap4A, and these were prevented by addition of the selective P2Y1 receptor antagonist MRS-2179 (2′-deoxy-N6-methyladenosine-3′,5′-diphosphate). Our results demonstrate that the hypotensive effect of Ap4A and other dinucleotides is mediated, at least in part, by increasing trabecular outflow facility through activation of P2Y1 receptors. The latter would seem to be an interesting target in the development of antiglaucomatous drugs to selectively increase AH outflow.

Footnotes

  • This work was supported by BFI2002-01202, BFI2003-01190, PI031495, SAF2003-00338, and FEDER UCOM03-33-024, Spain.

  • doi:10.1124/jpet.105.085274.

  • ABBREVIATIONS: IOP, intraocular pressure; AH, aqueous humor; TM, trabecular meshwork; Ap4A, P1,P4-diadenosine tetraphosphate; Ap5A, P1,P5-diadenosine pentaphosphate; PL, phospholipase; IP3, inositol 1,4,5-trisphosphate; PKC, protein kinase C; BSA, bovine serum albumin; DMEM, Dulbecco's modified Eagle's medium; PBS, phosphate-buffered saline; TRITC, tetramethylrhodamine B isothiocyanate; HPLC, high-performance liquid chromatography; Ap3A, P1,P3-diadenosine triphosphate; 2-MeSADP, 2-(methylthio) adenosine 5′-diphosphate; MRS-2179, 2′-deoxy-N6-methyladenosine-3′,5′-diphosphate; PPADS, pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid; Up4U, P1,P4-(diuridine 5′)-tetraphosphate; ANOVA, analysis of variance; [Ca2+]i, intracellular calcium concentration; INS37217, P1-(uridine 5′)-P4-(2′-deoxycytidine-5′)-tetraphosphate.

    • Received February 22, 2005.
    • Accepted June 7, 2005.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 377 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 377, Issue 2
1 May 2021
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Effects of Dinucleoside Polyphosphates on Trabecular Meshwork Cells and Aqueous Humor Outflow Facility
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCELLULAR AND MOLECULAR

Effects of Dinucleoside Polyphosphates on Trabecular Meshwork Cells and Aqueous Humor Outflow Facility

David Soto, Jesús Pintor, Assumpta Peral, Arcadi Gual and Xavier Gasull
Journal of Pharmacology and Experimental Therapeutics September 1, 2005, 314 (3) 1042-1051; DOI: https://doi.org/10.1124/jpet.105.085274

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleCELLULAR AND MOLECULAR

Effects of Dinucleoside Polyphosphates on Trabecular Meshwork Cells and Aqueous Humor Outflow Facility

David Soto, Jesús Pintor, Assumpta Peral, Arcadi Gual and Xavier Gasull
Journal of Pharmacology and Experimental Therapeutics September 1, 2005, 314 (3) 1042-1051; DOI: https://doi.org/10.1124/jpet.105.085274
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PARPi with vitamin C, decitabine or azacitidine for APL.
  • Circ-KRT6C/miR-485-3p/PDL1 axis in colorectal cancer.
  • Increased IL-10 by KCa3.1 Inhibition in Treg Cells
Show more Cellular and Molecular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics